CS208472B2 - Therapeutic agents - Google Patents

Therapeutic agents Download PDF

Info

Publication number
CS208472B2
CS208472B2 CS783579A CS357978A CS208472B2 CS 208472 B2 CS208472 B2 CS 208472B2 CS 783579 A CS783579 A CS 783579A CS 357978 A CS357978 A CS 357978A CS 208472 B2 CS208472 B2 CS 208472B2
Authority
CS
Czechoslovakia
Prior art keywords
formula
acid
dioxide
penicillanic acid
compound
Prior art date
Application number
CS783579A
Other languages
Czech (cs)
English (en)
Inventor
Wayne E Barth
Original Assignee
Wayne E Barth
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27122691&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CS208472(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wayne E Barth filed Critical Wayne E Barth
Publication of CS208472B2 publication Critical patent/CS208472B2/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CS783579A 1977-06-07 1978-06-01 Therapeutic agents CS208472B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80432077A 1977-06-07 1977-06-07
US87938178A 1978-02-21 1978-02-21

Publications (1)

Publication Number Publication Date
CS208472B2 true CS208472B2 (en) 1981-09-15

Family

ID=27122691

Family Applications (1)

Application Number Title Priority Date Filing Date
CS783579A CS208472B2 (en) 1977-06-07 1978-06-01 Therapeutic agents

Country Status (35)

Country Link
AR (1) AR224111A1 (no)
AT (2) AT360649B (no)
AU (1) AU513636B2 (no)
BE (1) BE867859A (no)
BG (2) BG34615A3 (no)
CH (1) CH634073A5 (no)
CS (1) CS208472B2 (no)
DD (2) DD148585A5 (no)
DE (2) DE2857263C3 (no)
DK (1) DK155740C (no)
EG (1) EG13869A (no)
FI (1) FI66003C (no)
FR (2) FR2393804A1 (no)
GB (1) GB2000138B (no)
GR (1) GR72255B (no)
HK (1) HK13184A (no)
HU (1) HU180042B (no)
IE (1) IE47079B1 (no)
IL (2) IL54867A (no)
IN (1) IN149747B (no)
IT (1) IT1096381B (no)
KE (1) KE3355A (no)
LU (1) LU79774A1 (no)
MY (1) MY8500092A (no)
NL (2) NL180009C (no)
NO (2) NO151746C (no)
NZ (1) NZ187476A (no)
OA (1) OA05964A (no)
PH (3) PH26810A (no)
PL (1) PL114501B1 (no)
PT (1) PT68146A (no)
SE (2) SE436206B (no)
SG (1) SG65383G (no)
SU (1) SU860706A1 (no)
YU (1) YU41829B (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU77306A1 (no) * 1977-05-09 1979-01-18
DE2912511C2 (de) * 1977-06-07 1982-06-24 Pfizer Inc., 10017 New York, N.Y. Pharmazeutische Zusammensetzung, enthaltend Penicillansäure
DK155942C (da) * 1977-12-23 1989-10-23 Pfizer Analogifremgangsmaade til fremstilling af 6-aminopenicillansyre-1,1-dioxid og fysiologisk acceptable syreadditions- og basesalte deraf.
JPS54126735A (en) * 1978-03-24 1979-10-02 Toyama Chem Co Ltd Bactericidal composition for medical use
US4241050A (en) * 1978-09-01 1980-12-23 Pfizer Inc. Penam 1,1-dioxides as beta-lactamase inhibitors
CA1158639A (en) * 1978-12-11 1983-12-13 Eric M. Gordon 6-bromopenicillanic acid sulfone
IE49881B1 (en) * 1979-02-13 1986-01-08 Leo Pharm Prod Ltd B-lactam intermediates
SE449103B (sv) * 1979-03-05 1987-04-06 Pfizer Sett att framstella penicillansyra-1,1-dioxid samt estrar derav
US4420426A (en) 1979-03-05 1983-12-13 Pfizer Inc. 6-Alpha-halopenicillanic acid 1,1-dioxides
US4714761A (en) * 1979-03-05 1987-12-22 Pfizer Inc. 6,6-dihalopenicillanic acid 1,1-dioxides and process
GB2045236A (en) * 1979-03-26 1980-10-29 Hoechst Uk Ltd Oxapenem derivatives
US4244951A (en) 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
US4309347A (en) * 1979-05-16 1982-01-05 Pfizer Inc. Penicillanoyloxymethyl penicillanate 1,1,1',1'-tetraoxide
IE49768B1 (en) * 1979-05-21 1985-12-11 Leo Pharm Prod Ltd 6beta-halopenicillanic acid derivatives
DE3051044C2 (no) * 1979-06-19 1989-03-30 Leo Pharmaceutical Products Ltd. A/S (Loevens Kemiske Fabrik Produktionsaktieselskab), Ballerup, Dk
US4256733A (en) * 1979-09-26 1981-03-17 Pfizer Inc. Acetoxymethyl penam compounds as β-lactamase inhibitors
US4432970A (en) * 1979-11-23 1984-02-21 Pfizer Inc. 6-beta-Halopenicillanic acid 1,1-dioxides as beta-lactamase inhibitors
IL61880A (en) * 1980-01-21 1984-11-30 Bristol Myers Co 2beta-chloromethyl-2alpha-methylpenam-3alpha-carboxylic acid sulfone derivatives,their preparation and pharmaceutical compositions containing them
US4432903A (en) * 1980-09-08 1984-02-21 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
US4488994A (en) * 1980-09-08 1984-12-18 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
US4474698A (en) * 1980-12-11 1984-10-02 Pfizer Inc. Process for preparing esters of penicillanic acid sulfone
US4419284A (en) * 1981-03-23 1983-12-06 Pfizer Inc. Preparation of halomethyl esters (and related esters) of penicillanic acid 1,1-dioxide
DE3261759D1 (en) * 1981-07-15 1985-02-14 Kanebo Ltd Novel ester of 1,1-dioxopenicillanic acid, process for production thereof, and use thereof as beta-lactamase inhibitor
PT76527B (en) * 1982-04-19 1985-12-09 Gist Brocades Nv A process for the preparation of penicillanic acid 1,1-dioxide and derivatives thereof
US4502988A (en) * 1983-08-08 1985-03-05 Eli Lilly And Company Oxidation process
EP0139047A1 (en) * 1983-10-18 1985-05-02 Gist-Brocades N.V. Process for the preparation of 6,6-dibromopenicillanic acid 1,1-dioxide
US4647457A (en) * 1983-12-16 1987-03-03 Hoffmann-La Roche Inc. Penicillanic acid derivatives
DE3780112T2 (de) * 1986-04-10 1992-12-24 Leo Pharm Prod Ltd Verfahren zur herstellung von penicillansaeure-derivaten.
GB8808701D0 (en) * 1988-04-13 1988-05-18 Erba Carlo Spa Beta-lactam derivatives
CN102977120B (zh) * 2012-12-14 2015-05-27 江西富祥药业股份有限公司 一种舒巴坦匹酯制备及结晶方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3197466A (en) * 1961-10-30 1965-07-27 Smith Kline French Lab Penicillin sulfoxides and process
LU77306A1 (no) * 1977-05-09 1979-01-18
EP0000636A1 (en) * 1977-07-13 1979-02-07 Glaxo Group Limited Penem compounds, processes for their preparation, their use in pharmaceutical compositions and azetidinones used in their preparation

Also Published As

Publication number Publication date
DK155740B (da) 1989-05-08
FI66003C (fi) 1984-08-10
IE47079B1 (en) 1983-12-14
SE8305916L (sv) 1983-10-27
NZ187476A (en) 1982-08-17
BG34614A3 (en) 1983-10-15
FR2393805B1 (no) 1984-02-24
IT1096381B (it) 1985-08-26
FR2393804B1 (no) 1980-11-07
SE7806628L (sv) 1978-12-08
FI781800A (fi) 1978-12-08
OA05964A (fr) 1981-06-30
YU117078A (en) 1983-01-21
SE8305916D0 (sv) 1983-10-27
DE2824535C3 (de) 1981-01-22
NL930064I1 (nl) 1993-09-01
FR2393804A1 (fr) 1979-01-05
PH26810A (en) 1992-11-05
NO781970L (no) 1978-12-08
PL114501B1 (en) 1981-02-28
PL207396A1 (pl) 1979-06-04
DE2857263C3 (de) 1981-12-17
AU3683878A (en) 1979-12-06
SG65383G (en) 1985-03-29
BE867859A (fr) 1978-12-06
DD140888A5 (de) 1980-04-02
IL54867A (en) 1981-11-30
IL62168A0 (en) 1981-03-31
CH634073A5 (en) 1983-01-14
IN149747B (no) 1982-04-03
IT7824270A0 (it) 1978-06-06
NL930064I2 (nl) 1994-04-18
IE781140L (en) 1978-12-07
ATA128580A (de) 1981-02-15
SU860706A1 (ru) 1981-08-30
AU513636B2 (en) 1980-12-11
HU180042B (en) 1983-01-28
DK155740C (da) 1989-10-23
MY8500092A (en) 1985-12-31
HK13184A (en) 1984-02-24
SE447995B (sv) 1987-01-12
PT68146A (en) 1978-07-01
NO152448C (no) 1985-10-02
SE436206B (sv) 1984-11-19
BG34615A3 (en) 1983-10-15
NL7806126A (nl) 1978-12-11
GB2000138A (en) 1979-01-04
PH21116A (en) 1987-07-16
ATA411278A (de) 1980-06-15
DD148585A5 (de) 1981-06-03
EG13869A (en) 1983-03-31
DK251478A (da) 1978-12-08
FR2393805A1 (fr) 1979-01-05
AR224111A1 (es) 1981-10-30
GB2000138B (en) 1982-03-03
DE2824535A1 (de) 1978-12-14
KE3355A (en) 1983-12-16
NO152448B (no) 1985-06-24
AT364084B (de) 1981-09-25
GR72255B (no) 1983-10-06
AT360649B (de) 1981-01-26
PH16465A (en) 1983-10-20
NO823126L (no) 1978-12-08
IL54867A0 (en) 1978-08-31
NO151746B (no) 1985-02-18
DE2857263B2 (de) 1981-04-23
LU79774A1 (fr) 1980-01-22
YU41829B (en) 1988-02-29
FI66003B (fi) 1984-04-30
NL180009C (nl) 1986-12-16
NO151746C (no) 1985-06-05
DE2824535B2 (de) 1980-05-14

Similar Documents

Publication Publication Date Title
CS208472B2 (en) Therapeutic agents
KR840000797B1 (ko) 6β-하이드록시알킬페니실란산 유도체의 제조방법
FR2477154A1 (fr) Bis-esters de methanediol avec des penicillines et le 1,1-dioxyde d'acide penicillanique, leur procede de production et composition pharmaceutique les contenant
JPS6259709B2 (no)
DK159159B (da) Analogifremgangsmaade til fremstilling af bis-estere af methandiol med et acetonid af ampicillin eller amoxicillin og penicillan-syre-1,1-dioxid eller farmaceutiske acceptable syreadditionssalte af disse bis-estere
JPS6056160B2 (ja) β−ラクタマ−ゼ阻害剤としてのペニシラン酸１，１−ジオキシド
WO2004052891A1 (fr) Composes heterocyclique, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens et inhibiteurs de beta-lactamases
KR900008677B1 (ko) 페니실린 유도체의 제조방법
SE461528B (sv) Mellanprodukter foer framstaellning av acetoximetyl-penamfoereningar, som aer anvaendbara som -laktamasinhibitorer
KR920005829B1 (ko) 2β-치환된 티오메틸페니실린 유도체 및 그의 염의 제조방법
CS228919B2 (en) Method of preparing halogenomethylester of 1,1-dioxide of penicillanic acid
JPS6033397B2 (ja) ペナム−１，１−ジオキシド
KR850001339B1 (ko) 페니실란산 1,1-디옥사이드 및 그의 에스테르의 제조방법
CS236681B2 (en) Manufacturing process of 1,1-dioxide ester 2beta-substituted 2alfa-methyl 5r penam-3alfa-carboxyl acid
US4452796A (en) 6-Aminoalkylpenicillanic acid 1,1-dioxides as beta-lactamase inhibitors
KR910009271B1 (ko) 1,1-디옥소페닐실라노일 옥시메틸 D-6-[α-(메틸렌아미노)페닐-아세트아미도]-페니실라네이트와 그의 파라-톨루엔술폰산염
JPS6145993B2 (no)
HU189211B (en) Process for preparing 1,1-dioxides of 6-amnioalkyl-penam-3-carboxylic acid and derivatives thereof applied as beta-lactamase inhibitors
HU182663B (en) Process for preparing 1,1-dioxo-penicillanoyl-oxy-alkyl-penicillanate derivatives
US4427678A (en) 6-Aminomethylpenicillanic acid 1,1-dioxide derivatives as beta-lactamase inhibitors
KR820000740B1 (ko) 페니실란산 1, 1-디옥사이드의 제조방법
CA1198729A (en) 6-aminoalkylpenicillanic acid 1,1-dioxides and derivatives as beta-lactamase inhibitors
KR810002025B1 (ko) 페니실란산 1, 1-디옥사이드의 제조방법
KR830001902B1 (ko) 폐니실란산유도체의 제조방법
CA1119164A (en) PENICILLANIC ACID 1,1-DIOXIDES AS .beta.-LACTAMASE INHIBITORS